Label-Free Array Systems Market Is Estimated to Reach US $1,722.9 Million in Terms of Value by 2024-End
In recent years, label-free array systems have taken a center stage as the research tool in many drug discovery processes. Label-free technologies are also used by manufacturers in context to patient samples to produce bio-relevant data that can result in effective drug development and precision medicine. Attana AB, Agilent Technologies, Biacore, F. Hoffmann-La Roche AG, ForteBio, PerkinElmer, Inc., GWC Technologies, Riot Block chain Inc., Molecular Devices LLC, and Bio-Rad Laboratories, are some of the leading companies in the global Label-Free...
View full press release